This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Clair, W. K. Articles by Pritchett, E. L. Search for Related Content PubMed PubMed Citation Articles by Clair, W. K. Articles by Pritchett, E. L. Pubmed/NCBI databases Medline Plus Health Information Atrial Fibrillation

Circulation, Vol 87, 1114-1122, Copyright © 1993 by American Heart Association

ARTICLES

Spontaneous occurrence of symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia in untreated patients

WK Clair, WE Wilkinson, EA McCarthy, RL Page and EL Pritchett
Department of Medicine, Duke University Medical Center, Durham, N.C. 27710.

BACKGROUND. Ambulatory outpatients (n = 150) with a history of paroxysmal supraventricular arrhythmia were studied to establish the characteristics of the first recurrence of symptomatic tachycardia (time to first recurrence, heart rate during tachycardia, and observed rhythm that was regular versus irregular) when no antiarrhythmic drug was being taken. Baseline variables were examined to assess their impact on time to first recurrence: index arrhythmia (paroxysmal atrial fibrillation [n = 37] versus paroxysmal supraventricular tachycardia [n = 113]), age (mean +/- SD, 43.3 +/- 16.1 years), female sex (n = 71), or presence of other heart or lung disease (n = 53). METHODS AND RESULTS. Transtelephonic monitoring of the ECG was used to document the rhythm during recurrences of symptomatic tachycardia. Time to first recurrence of symptomatic tachycardia and heart rate during tachycardia were measured, the observed rhythm was classified as irregular (consistent with paroxysmal atrial fibrillation) or regular (consistent with paroxysmal supraventricular tachycardia), and the hour of recurrence was recorded. Advancing age was significantly associated with a decreasing time to first recurrence (p < 0.001); the estimated increase in the hazard function was 25% with each 10 years of advancing age. After the effect of age was adjusted for, neither the classification of arrhythmia (p > 0.2), presence of other heart or lung disease (p > 0.8), nor sex (p > 0.9) was significantly associated with time to first recurrence. Among patients with paroxysmal supraventricular tachycardia, 6.5% had atrial fibrillation recorded at the next symptomatic arrhythmia; among patients with paroxysmal atrial fibrillation, 11.8% had a regular tachycardia recorded at the next symptomatic arrhythmia. There was a circadian pattern to the hour of occurrence of paroxysmal supraventricular tachycardia but not paroxysmal atrial fibrillation. CONCLUSIONS. Age is more important than other clinical variables, including the ECG classification of a paroxysmal supraventricular arrhythmia in predicting the occurrence of symptomatic arrhythmias. Arrhythmias documented by ECG during symptoms are often different from the arrhythmia documented at the time of referral, which may confound interpretation of antiarrhythmic drug effects.

This article has been cited by other articles:

				L. Padeletti, M. Santini, G. Boriani, G. Botto, A. Capucci, M. Gulizia, R. Ricci, A. Spampinato, P. Pieragnoli, E. Warman, et al. Temporal variability of atrial tachyarrhythmia burden in bradycardia-tachycardia syndrome patients Eur. Heart J., January 2, 2005; 26(2): 165 - 172. [Abstract] [Full Text] [PDF]

				R. L. Page, T. W. Tilsch, S. J. Connolly, D. J. Schnell, S. R. Marcello, W. E. Wilkinson, E. L.C. Pritchett, and for the Azimilide Supraventricular Arrhythmia Prog Asymptomatic or "Silent" Atrial Fibrillation: Frequency in Untreated Patients and Patients Receiving Azimilide Circulation, March 4, 2003; 107(8): 1141 - 1145. [Abstract] [Full Text] [PDF]

				N. Bottoni, C. Tomasi, P. Donateo, G. Lolli, N. Muią, F. Croci, D. Oddone, C. Menozzi, and M. Brignole Clinical and electrophysiological characteristics in patients with atrioventricular reentrant and atrioventricular nodal reentrant tachycardia Europace, January 1, 2003; 5(3): 225 - 229. [Abstract] [Full Text] [PDF]

				P. A. Friedman, B. Dijkman, E. N. Warman, H. A. Xia, R. Mehra, M. S. Stanton, and S. C. Hammill Atrial Therapies Reduce Atrial Arrhythmia Burden in Defibrillator Patients Circulation, August 28, 2001; 104(9): 1023 - 1028. [Abstract] [Full Text] [PDF]

				A. Natale, K. H. Newby, E. Pisano, F. Leonelli, R. Fanelli, D. Potenza, S. Beheiry, and G. Tomassoni Prospective randomized comparison of antiarrhythmic therapy versus first-line radiofrequency ablation in patients with atrial flutter J. Am. Coll. Cardiol., June 1, 2000; 35(7): 1898 - 1904. [Abstract] [Full Text] [PDF]

				E. S. Zado, D. J. Callans, C. D. Gottlieb, S. P. Kutalek, S. L. Wilbur, F. L. Samuels, S. E. Hessen, C. M. Movsowitz, J. M. Fontaine, S. E. Kimmel, et al. Efficacy and safety of catheter ablation in octogenarians J. Am. Coll. Cardiol., February 1, 2000; 35(2): 458 - 462. [Abstract] [Full Text] [PDF]

				P. Coumel Editorials: The various forms of clinical research concerning paroxysmal atrial fibrillation Eur. Heart J., October 1, 1999; 20(19): 1369 - 1370. [PDF]

				M. H. Crawford, S. J. Bernstein, P. C. Deedwania, J. P. DiMarco, K. J. Ferrick, A. Garson Jr, L. A. Green, H. L. Greene, M. J. Silka, P. H. Stone, et al. ACC/AHA guidelines for ambulatory electrocardiography: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the Guidelines for Ambulatory Electrocardiography) developed in collaboration with the North American Society for Pacing and Electrophysiology J. Am. Coll. Cardiol., September 1, 1999; 34(3): 912 - 948. [Full Text] [PDF]

				H. Paydak, J. G. Kall, M. C. Burke, D. Rubenstein, D. E. Kopp, R. J. Verdino, and D. J. Wilber Atrial Fibrillation After Radiofrequency Ablation of Type I Atrial Flutter : Time to Onset, Determinants, and Clinical Course Circulation, July 28, 1998; 98(4): 315 - 322. [Abstract] [Full Text] [PDF]

				Treatment of Atrial Fibrillation and Paroxysmal Supraventricular Tachycardia With Bidisomide Circulation, October 21, 1997; 96(8): 2625 - 2632. [Abstract] [Full Text]

				T. Yamashita, Y. Murakawa, K. Sezaki, M. Inoue, N. Hayami, Y. Shuzui, and M. Omata Circadian Variation of Paroxysmal Atrial Fibrillation Circulation, September 2, 1997; 96(5): 1537 - 1541. [Abstract] [Full Text]

				T. J. Lessmeier, D. Gamperling, V. Johnson-Liddon, B. S. Fromm, R. T. Steinman, M. D. Meissner, and M. H. Lehmann Unrecognized Paroxysmal Supraventricular Tachycardia: Potential for Misdiagnosis as Panic Disorder Arch Intern Med, March 10, 1997; 157(5): 537 - 543. [Abstract] [PDF]

				S.-A. Chen, C.-E. Chiang, C.-T. Tai, S.-H. Lee, C.-W. Chiou, K.-C. Ueng, Z.-C. Wen, C.-C. Cheng, and M.-S. Chang Longitudinal Clinical and Electrophysiological Assessment of Patients With Symptomatic Wolff-Parkinson-White Syndrome and Atrioventricular Node Reentrant Tachycardia Circulation, June 1, 1996; 93(11): 2023 - 2032. [Abstract] [Full Text]